Rheumatology Doctors in Tyler, TX Accepting Medicare

7 Rheumatology doctors found. Showing 1 - 7

Dr. Elizabeth Bui, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 11937 Us Highway 271, Tyler, TX 75708 Phone: 903-877-7200    Fax: 903-877-7933

Dr. Chih- Hao G Chou, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1327 Troup Hwy, Tyler, TX 75701 Phone: 903-510-8764

Heidi E. Schneider, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1327 Troup Hwy, Tyler, TX 75701 Phone: 903-510-8764

Dr. Glen S Graves, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5777 New Copeland Rd, Suite 100, Tyler, TX 75703 Phone: 903-561-9255    Fax: 903-561-0034

William George Brelsford, MD, FACP, FACR Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 1212 Clinic Dr, Tyler, TX 75701 Phone: 903-596-8858    Fax: 903-535-9138

Roger William Porter, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 11937 Us Highway 271, Tyler, TX 75708 Phone: 903-877-3451

Dustin Stidger, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1327 Troup Hwy, Tyler, TX 75701 Phone: 903-606-2100

News Archive

First Edition: March 20, 2014

Today's headlines include reports about how the GOP is challenging the Obama administration's authority regarding the health law on various fronts, including the employer mandate delay and the birth control coverage mandate.

Boehringer Ingelheim's interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD

Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.

Combination therapy places no greater burden on early-stage breast cancer patients

Adding an immune checkpoint inhibitor to the standard chemotherapy regimen for patients with early-stage breast cancer places no greater burden on patients' ability to perform day-to-day activities than chemotherapy alone, new research by Dana-Farber/Brigham and Women's Cancer Center investigators shows.

Protein indoleamine 2,3-dioxygenase points to new pancreatic cancer therapies

An enzyme that is overexpressed in pancreatic cancer cells may hold the key to successfully treating the disease with targeted immunotherapy, researchers from Thomas Jefferson University reported at the 2008 Annual Meeting of the Southern Surgical Association.

Read more Medical News

› Verified 4 days ago